| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
INSERM Unit 460, UFR de Médecine X. Bichat, Paris, France;
* CJF INSERM 9503, Institut Claudius Régaud, Toulouse, France; and
INSERM Unit 466, Laboratoire de Biochimie Médicale, Centre Hospitalier Universitaire de Rangueil, Toulouse, France
1Correspondence: INSERM U.460, UFR de Médecine X. Bichat, 16 rue Henri Huchard, 75870 PARIS Cedex 18 France. E-mail: andrieu{at}bichat.inserm.fr
Besides the well-documented effect of the chemotherapeutic drug doxorubicin on free radical generation, the exact signaling mechanisms by which it causes cardiac damage remain largely unknown and are of fundamental importance in understanding anthracycline cardiotoxicity. In this study, we describe that a 1 h treatment of isolated adult rat cardiac myocytes with doxorubicin (0.5 µM) induced DNA fragmentation associated with the classical morphological features of apoptosis observed after 7 days of culture. The doxorubicin toxicity was preceded by an increase in intracellular ceramide levels with a concurrent decrease in sphingomyelin. Anthracycline-induced ceramide accumulation resulted from the activation of a sphingomyelinase assayed under acidic conditions, an effect related to an increase in Vmax. Pretreatment of cardiac myocytes with L-carnitine (200 µg/ml), a compound known for its protective effect on cardiac metabolic injuries, was found to dose-dependently inhibit the doxorubicin-induced sphingomyelin hydrolysis and ceramide generation as well as subsequent cell death. However, L-carnitine did not protect cardiac myocytes from apoptosis induced by exogenous cell-permeant ceramide. L-carnitine pretreatment did not affect the sphingomyelinase basal activity but abolished the doxorubicin-induced increase in Vmax. Moreover, in vitro studies conducted on cell extracts or with purified acid sphingomyelinase demonstrated that L-carnitine exerted a dose-dependent, sphingomyelinase inhibitory effect (through Vmax reduction). Taken together, these findings show that by inhibiting a (perhaps novel) drug-activated acid sphingomyelinase and ceramide generation, L-carnitine can prevent doxorubicin-induced apoptosis of cardiac myocytes.—Andrieu-Abadie, N., Jaffrézou, J.-P., Hatem, S., Laurent, G., Levade, T., Mercadier, J.-J. L-carnitine prevents doxorubicin-induced apoptosis of cardiac myocytes: role of inhibition of ceramide generation.
Key Words: staurosporine • cardiotoxicity • oxidative stress • tumor necrosis factor
This article has been cited by other articles:
|
|
 |
|
  C. A. Corcoran, Q. He, S. Ponnusamy, B. Ogretmen, Y. Huang, and M. S. Sheikh Neutral Sphingomyelinase-3 Is a DNA Damage and Nongenotoxic Stress-Regulated Gene That Is Deregulated in Human Malignancies Mol. Cancer Res., May 1, 2008; 6(5): 795 - 807. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-C. Lien, S.-M. Lin, R. Nithipongvanitch, T. D. Oberley, T. Noel, Q. Zhao, C. Daosukho, and D. K. St. Clair Tumor necrosis factor receptor deficiency exacerbated Adriamycin-induced cardiomyocytes apoptosis: an insight into the Fas connection. Mol. Cancer Ther., February 1, 2006; 5(2): 261 - 269. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Schreiber Levocarnitine and Dialysis: A Review Nutr Clin Pract, April 1, 2005; 20(2): 218 - 243. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Minotti, P. Menna, E. Salvatorelli, G. Cairo, and L. Gianni Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity Pharmacol. Rev., June 1, 2004; 56(2): 185 - 229. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. FOGLI, P. NIERI, and M. C. BRESCHI The role of nitric oxide in anthracycline toxicity and prospects for pharmacologic prevention of cardiac damage FASEB J, April 1, 2004; 18(6): 664 - 675. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Liu and R. H. Kennedy Positive inotropic effect of ceramide in adult ventricular myocytes: mechanisms dissociated from its reduction in Ca2+ influx Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H735 - H744. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Yamanaka, T. Tatsumi, J. Shiraishi, A. Mano, N. Keira, S. Matoba, J. Asayama, S. Fushiki, H. Fliss, and M. Nakagawa Amlodipine inhibits doxorubicin-induced apoptosis in neonatal rat cardiac myocytes J. Am. Coll. Cardiol., March 5, 2003; 41(5): 870 - 878. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Gouaze, N. Andrieu-Abadie, O. Cuvillier, S. Malagarie-Cazenave, M.-F. Frisach, M.-E. Mirault, and T. Levade Glutathione Peroxidase-1 Protects from CD95-induced Apoptosis J. Biol. Chem., November 1, 2002; 277(45): 42867 - 42874. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Vescovo, B. Ravara, V. Gobbo, M. Sandri, A. Angelini, M. Della Barbera, M. Dona, G. Peluso, M. Calvani, L. Mosconi, et al. L-Carnitine: a potential treatment for blocking apoptosis and preventing skeletal muscle myopathy in heart failure Am J Physiol Cell Physiol, September 1, 2002; 283(3): C802 - C810. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Levade, N. Auge, R. J. Veldman, O. Cuvillier, A. Negre-Salvayre, and R. Salvayre Sphingolipid Mediators in Cardiovascular Cell Biology and Pathology Circ. Res., November 23, 2001; 89(11): 957 - 968. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Gouaze, M.-E. Mirault, S. Carpentier, R. Salvayre, T. Levade, and N. Andrieu-Abadie Glutathione Peroxidase-1 Overexpression Prevents Ceramide Production and Partially Inhibits Apoptosis in Doxorubicin-Treated Human Breast Carcinoma Cells Mol. Pharmacol., September 1, 2001; 60(3): 488 - 496. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Henaff, S. N. Hatem, and J.-J. Mercadier Low Catecholamine Concentrations Protect Adult Rat Ventricular Myocytes against Apoptosis through cAMP-Dependent Extracellular Signal-Regulated Kinase Activation Mol. Pharmacol., April 13, 2001; 58(6): 1546 - 1553. [Abstract] [Full Text]
|
|
|
|
|
|
C. BLÁZQUEZ, I. GALVE-ROPERH, and M. GUZMÁN De novo-synthesized ceramide signals apoptosis in astrocytes via extracellular signal-regulated kinase FASEB J, November 1, 2000; 14(14): 2315 - 2322. [Abstract] [Full Text]
|
|
|
|
|
|
G. L. Semenza Cellular and Molecular Dissection of Reperfusion Injury : ROS Within and Without Circ. Res., February 4, 2000; 86(2): 117 - 118. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
